Mitsubishi UFJ Asset Management Co. Ltd. Increases Holdings in Cardinal Health, Inc. $CAH

Key Points

• Mitsubishi UFJ Asset Management increased its stake in Cardinal Health by 5.0% in Q4, adding 25,327 shares to hold 529,850 shares (about 0.22% of the company) valued at roughly $109 million.
• Cardinal Health beat quarterly EPS estimates, reporting $3.17 vs. $2.79 consensus with revenue up 11% year-over-year (but slightly below estimates), and set FY2026 guidance of $10.70–$10.80 EPS (consensus ~10.76).
• Dividend raised: the company declared a quarterly dividend of $0.5158 ($2.06 annualized), implying a ~1.1% yield, with an ex-dividend/record date on July 1 and payment on July 15.

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 529,850 shares of the company's stock after buying an additional 25,327 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.22% of Cardinal Health worth $109,001,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in CAH. Aventura Private Wealth LLC purchased a new position in Cardinal Health in the 4th quarter worth $25,000. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in Cardinal Health during the 3rd quarter valued at $31,000. Turning Point Benefit Group Inc. purchased a new stake in shares of Cardinal Health during the third quarter worth about $31,000. Finally, American Capital Advisory LLC lifted its holdings in Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company's stock worth $33,000 after buying an additional 208 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 2.8%

NYSE:CAH opened at $191.41 on Thursday. The stock has a market cap of $44.83 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.17 and a beta of 0.53. The company's 50 day moving average price is $212.52 and its 200-day moving average price is $206.74. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts' consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm's revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.19%.

Analysts Set New Price Targets

A number of research analysts have weighed in on CAH shares. Barclays upped their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an "overweight" rating in a report on Tuesday, February 24th. JPMorgan Chase & Co. cut their price target on Cardinal Health from $243.00 to $215.00 and set a "neutral" rating on the stock in a research note on Monday. Weiss Ratings upgraded Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Monday. Evercore dropped their target price on Cardinal Health from $260.00 to $240.00 and set an "outperform" rating on the stock in a report on Wednesday, April 8th. Finally, Jefferies Financial Group increased their target price on Cardinal Health from $220.00 to $270.00 and gave the stock a "buy" rating in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.